n/a
Abstract Title:

Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment.

Abstract Source:

Pathol Res Pract. 2020 Mar 9:152919. Epub 2020 Mar 9. PMID: 32171553

Abstract Author(s):

Nazila Fathi Maroufi, Vahid Vahedian, Saideh Hemati, Mohammad-Reza Rashidi, Maryam Akbarzadeh, Mohammadsaeid Zahedi, Farhad Pouremamali, Alireza Isazadeh, Sina Taefehshokr, Saba Hajazimian, Nikou Seraji, Mohammad Nouri

Article Affiliation:

Nazila Fathi Maroufi

Abstract:

Melatonin is a physiological hormone produced by the pineal gland. In recent decades, enormous investigations showed that melatonin can prompt apoptosis in cancer cells and inhibit tumor metastasis and angiogenesis in variety of malignancies such as ovarian, melanoma, colon, and breast cancer; therefore, its possible therapeutic usage in cancer treatment was confirmed. CSCs, which has received much attention from researchers in past decades, are major challenges in the treatment of cancer. Because CSCs are resistant to chemotherapeutic drugs and cause recurrence of cancer and also have the ability to be regenerated; they can cause serious problems in the treatment of various cancers. For these reasons, the researchers are trying to find a solution to destroy these cells within the tumor mass. In recent years, the effect of melatonin on CSCs has been investigated in some cancers. Given the importance of CSCs in the process of cancer treatment, this article reviewed the studies conducted on the effect of melatonin on CSCs as a solution to the problems caused by CSCs in the treatment of various cancers.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.